1
TITLE: Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives  Full Text
AUTHORS: De Mello, RAB; Voscaboinik, R; Luciano, JVP; Cremonese, RV; Amaral, GA; Castelo Branco, P; Antoniou, G;
PUBLISHED: 2022, SOURCE: CANCERS, VOLUME: 14, ISSUE: 1
INDEXED IN: WOS CrossRef: 12
IN MY: ORCID
2
TITLE: The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic
AUTHORS: Katia Roque; Rossana Ruiz; Iris Otoya-Fernandez; José Galarreta; Tatiana Vidaurre; Ramon Andrade de Mello; Silvia Neciosup; Luis Mas; Henry Gómez;
PUBLISHED: 2022, SOURCE: Future Oncology, VOLUME: 18, ISSUE: 31
INDEXED IN: CrossRef: 1
IN MY: ORCID
3
TITLE: Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer  Full Text
AUTHORS: Zhu, GS; Ren, D; Lei, X; Shi, RF; Zhu, S; Zhou, N; Zu, LL; De Mello, RA; Chen, J; Xu, S;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
4
TITLE: Potential role of immunotherapy for advanced breast cancer
AUTHORS: de Mello, RA; Amaral, GA; Tajima, CC; Tadokoro, H; Iavelberg, J; Simonetti, D; Tolia, M; Silva, JA;
PUBLISHED: 2021, SOURCE: IMMUNOTHERAPY, VOLUME: 13, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
5
TITLE: Current and potential biomarkers in gastric cancer: a critical review of the literature
AUTHORS: de Mello, RA; Amaral, GA; Neves, NM; Lippo, EG; Parini, F; Xu, S; Tolia, M; Charalampakis, N; Tadokoro, H; Castelo Branco, P; Zhu, JH;
PUBLISHED: 2021, SOURCE: FUTURE ONCOLOGY, VOLUME: 17, ISSUE: 25
INDEXED IN: WOS CrossRef: 11
IN MY: ORCID
6
TITLE: Prognostic role of 18F-FDG PET-CT in the prone position in the evaluation of invasive breast carcinoma
AUTHORS: Carla Chizuru Tajima; Eduardo Nóbrega Pereira Lima; Ramon Andrade Bezerra de Mello; Elvira Ferreira Marques; Almir Galvão Vieira Bitencourt;
PUBLISHED: 2021, SOURCE: Mastology, VOLUME: 31
INDEXED IN: CrossRef
IN MY: ORCID
7
TITLE: Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers?  Full Text
AUTHORS: Hélder Almeida-Lousada; André Mestre; Sara Ramalhete; Aryeh J Price; Ramon Andrade de Mello; Ana D Marreiros; Ricardo Pires das Neves; Pedro Castelo-Branco;
PUBLISHED: 2021, SOURCE: Current Oncology, VOLUME: 28, ISSUE: 6
INDEXED IN: CrossRef: 7
IN MY: ORCID
8
TITLE: Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
AUTHORS: de Mello, RA; Amaral, GA;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
9
TITLE: New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
AUTHORS: de Mello, RA; Neves, NM; Tadokoro, H; Amaral, GA; Castelo Branco, P; Zia, VAD;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 11
INDEXED IN: WOS CrossRef: 22
IN MY: ORCID
10
TITLE: Role of genetic polymorphisms in the angiogenesis pathway and non-small-cell lung cancer tumor behavior: Implications in risk assessment and clinical outcome
AUTHORS: de Mello, AR; Luis, M; Araújo, A; Reis, RM; Hespanhol, V ;
PUBLISHED: 2013, SOURCE: Biochemical Basis and Therapeutic Implications of Angiogenesis
INDEXED IN: Scopus CrossRef: 3
IN MY: ORCID
Page 1 of 3. Total results: 22.